LPCAT3 Antikörper (AA 306-363) (FITC)

Produktnummer ABIN7158762

Produktdetails anti-LPCAT3 Antikörper (FITC)

Target: LPCAT3 (Lysophosphatidylcholine Acyltransferase 3 (LPCAT3))

Bindungsspezifität: AA 306-363

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LPCAT3 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Lysophospholipid acyltransferase 5 protein (306-363AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu LPCAT3

Target: LPCAT3 (Lysophosphatidylcholine Acyltransferase 3 (LPCAT3))

Andere Bezeichnung: LPCAT3 (LPCAT3 Produkte)

Synonyme: c3f antikoerper, lpcat antikoerper, lpcat3 antikoerper, lpsat antikoerper, mboat5 antikoerper, nessy antikoerper, oact5 antikoerper, MBOAT5 antikoerper, Grcc3f antikoerper, Mboat5 antikoerper, Oact5 antikoerper, C3F antikoerper, LPCAT antikoerper, LPLAT 5 antikoerper, LPSAT antikoerper, OACT5 antikoerper, C3f antikoerper, Lpcat antikoerper, Lpeat antikoerper, Lplat5 antikoerper, Lpsat antikoerper, Moact5 antikoerper, PTG antikoerper, GRCC3F antikoerper, lysophosphatidylcholine acyltransferase 3 S homeolog antikoerper, lysophosphatidylcholine acyltransferase 3 antikoerper, lpcat3.S antikoerper, LPCAT3 antikoerper, lpcat3 antikoerper, Lpcat3 antikoerper

Hintergrund:

Background: Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle.

Aliases: 1-acylglycerophosphocholine O-acyltransferase antibody, 1-acylglycerophosphoserine O-acyltransferase antibody, LPCAT antibody, Lpcat3 antibody, LPLAT 5 antibody, LPSAT antibody, Lyso-PC acyltransferase 3 antibody, Lyso-PC acyltransferase antibody, Lyso-PS acyltransferase antibody, Lysophosphatidylcholine acyltransferase 3 antibody, Lysophosphatidylcholine acyltransferase antibody, Lysophosphatidylserine acyltransferase antibody, Lysophospholipid acyltransferase 5 antibody, MBOA5 antibody, MBOA5_HUMAN antibody, Membrane-bound O-acyltransferase domain-containing protein 5 antibody, O-acyltransferase domain-containing protein 5 antibody

UniProt: Q6P1A2